These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9623977)

  • 61. E2F as a regulator of keratinocyte proliferation: implications for skin tumor development.
    Jones SJ; Dicker AJ; Dahler AL; Saunders NA
    J Invest Dermatol; 1997 Aug; 109(2):187-93. PubMed ID: 9242506
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis.
    Qin XQ; Livingston DM; Kaelin WG; Adams PD
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10918-22. PubMed ID: 7971984
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Oncogenic capacity of the E2F1 gene.
    Johnson DG; Cress WD; Jakoi L; Nevins JR
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12823-7. PubMed ID: 7809128
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 65. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.
    Nevins JR
    Science; 1992 Oct; 258(5081):424-9. PubMed ID: 1411535
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1.
    Schulze A; Zerfass K; Spitkovsky D; Henglein B; Jansen-Dürr P
    Oncogene; 1994 Dec; 9(12):3475-82. PubMed ID: 7970707
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Small contribution of G1 checkpoint control manipulation to modulation of p53-mediated apoptosis.
    Canman CE; Kastan MB
    Oncogene; 1998 Feb; 16(8):957-66. PubMed ID: 9519869
    [TBL] [Abstract][Full Text] [Related]  

  • 68. p53 gene transfer does not enhance E2F-1-mediated apoptosis in human colon cancer cells.
    Draus JM; Elliott MJ; Atienza C; Stilwell A; Wong SL; Dong Y; Yang H; McMasters KM
    Exp Mol Med; 2001 Dec; 33(4):209-19. PubMed ID: 11795482
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Caspase-dependent apoptosis by ectopic expression of E2F-4.
    Chang YC; Nakajima H; Illenye S; Lee YS; Honjo N; Makiyama T; Fujiwara I; Mizuta N; Sawai K; Saida K; Mitsui Y; Heintz NH; Magae J
    Oncogene; 2000 Sep; 19(41):4713-20. PubMed ID: 11032021
    [TBL] [Abstract][Full Text] [Related]  

  • 70. E2F-1-induced p53-independent apoptosis in transgenic mice.
    Holmberg C; Helin K; Sehested M; Karlström O
    Oncogene; 1998 Jul; 17(2):143-55. PubMed ID: 9674698
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice.
    Yamasaki L; Bronson R; Williams BO; Dyson NJ; Harlow E; Jacks T
    Nat Genet; 1998 Apr; 18(4):360-4. PubMed ID: 9537419
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The cellular effects of E2F overexpression.
    Adams PD; Kaelin WG
    Curr Top Microbiol Immunol; 1996; 208():79-93. PubMed ID: 8575214
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
    Fuxe J; Akusjärvi G; Goike HM; Roos G; Collins VP; Pettersson RF
    Cell Growth Differ; 2000 Jul; 11(7):373-84. PubMed ID: 10939591
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Adenovirus E4 open reading frame 4-induced dephosphorylation inhibits E1A activation of the E2 promoter and E2F-1-mediated transactivation independently of the retinoblastoma tumor suppressor protein.
    Mannervik M; Fan S; Ström AC; Helin K; Akusjärvi G
    Virology; 1999 Apr; 256(2):313-21. PubMed ID: 10191196
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Regulation of the retinoblastoma-dependent Mdm2 and E2F-1 signaling pathways during neuronal apoptosis.
    Trinh E; Boutillier AL; Loeffler JP
    Mol Cell Neurosci; 2001 Feb; 17(2):342-53. PubMed ID: 11178871
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status.
    Ito H; Kanzawa T; Miyoshi T; Hirohata S; Kyo S; Iwamaru A; Aoki H; Kondo Y; Kondo S
    Hum Gene Ther; 2005 Jun; 16(6):685-98. PubMed ID: 15960600
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Analysis of downstream effectors of p53 on cell growth arrest and apoptosis induced by a temperature-sensitive Val138 mutant.
    Wang FJ
    J Med Dent Sci; 1998 Jun; 45(2):141-9. PubMed ID: 11186200
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Control of E2F activity by p21Waf1/Cip1.
    Delavaine L; La Thangue NB
    Oncogene; 1999 Sep; 18(39):5381-92. PubMed ID: 10498892
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
    Palmero I; Murga M; Zubiaga A; Serrano M
    Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
    [TBL] [Abstract][Full Text] [Related]  

  • 80. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters.
    Robertson KD; Ait-Si-Ali S; Yokochi T; Wade PA; Jones PL; Wolffe AP
    Nat Genet; 2000 Jul; 25(3):338-42. PubMed ID: 10888886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.